Composition
- Active ingredients
- NISOLDIPINE 17MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NISOLDIPINE 25.5MG · Tablet, extended releaseANDA091001-003 · Discontinued
- NISOLDIPINE 8.5MG · Tablet, extended releaseANDA091001-001 · Discontinued
- NISOLDIPINE 34MG · Tablet, extended releaseANDA091001-004 · Discontinued
- NISOLDIPINE 17MG · Tablet, extended releaseThis page
- NISOLDIPINE 40MG · Tablet, extended releaseANDA079051-003 · Discontinued
- NISOLDIPINE 20MG · Tablet, extended releaseANDA079051-001 · Discontinued
- NISOLDIPINE 30MG · Tablet, extended releaseANDA079051-002 · Discontinued
- NISOLDIPINE 8.5MG · Tablet, extended releaseANDA216606-001 · Prescription
- NISOLDIPINE 17MG · Tablet, extended releaseANDA216606-002 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA091001.
At a glance
- Brand name
- Nisoldipine
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Mylan
- Status
- Discontinued
- FDA approval
- 26 Jan 2011
- Application
- ANDA091001-002